Flordis Iberogast is clinically proven for the treatment of abdominal discomfort associated with conditions such as Irritable Bowel Syndrome (IBS) and functional dyspepsia. Researched in 20 studies, involving more than 50,000 patients, Iberogast has been used by millions of patients since it was first launched in Europe over 50 years ago. Iberogast has been clinically proven to treat the discomfort experienced with Irritable Bowel Syndrome (IBS) and functional dyspepsia. The multi-targeted action of Iberogast is able to improve the many symptoms associated with IBS and functional dyspepsia, which can include: Heartburn/acid reflux Indigestion Nausea / vomiting Early satiety Feeling of fullness Epigastric pain Bloating / abdominal cramping Gas Constipation / diarrhoea Iberogast’s unique multi-targeted formulation is clinically proven, it is the exact product used in clinical trials. This is very important for natural medicines, as there can be a great deal of variability between products, even if they appear to use the same active ingredients. This is due to the part of the plant that is used, growing methods, harvesting processes and manufacturing methods. The outcomes of clinical studies for natural medicines should therefore only apply to the exact product that has been tested. Iberogast’s safety and efficacy has been extensively researched in over 45,000 patients of all age groups, from babies to adults, in 19 clinical trials. Iberogast has no known interactions with other medications and is very well tolerated.3,4 It has been used extensively for more than 50 years and there have been no significant adverse reactions reported in the literature or to the health authorities of different countries.